KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Illumina (ILMN) Other Non Operating Income (2016 - 2025)

Illumina's Other Non Operating Income history spans 17 years, with the latest figure at $192.0 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 611.11% year-over-year to $192.0 million; the TTM value through Dec 2025 reached $340.0 million, up 216.04%, while the annual FY2025 figure was $340.0 million, 216.44% up from the prior year.
  • Other Non Operating Income reached $192.0 million in Q4 2025 per ILMN's latest filing, up from $9.0 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $979.0 million in Q4 2021 to a low of -$1.2 billion in Q1 2023.
  • Average Other Non Operating Income over 5 years is -$3.0 million, with a median of $4.0 million recorded in 2023.
  • Peak YoY movement for Other Non Operating Income: surged 4275.0% in 2021, then plummeted 33300.0% in 2024.
  • A 5-year view of Other Non Operating Income shows it stood at $979.0 million in 2021, then plummeted by 101.23% to -$12.0 million in 2022, then surged by 133.33% to $4.0 million in 2023, then soared by 575.0% to $27.0 million in 2024, then surged by 611.11% to $192.0 million in 2025.
  • Per Business Quant, the three most recent readings for ILMN's Other Non Operating Income are $192.0 million (Q4 2025), $9.0 million (Q3 2025), and $107.0 million (Q2 2025).